Exploring Oncology Clinical Design
Webinar date & time: March 9th 14:00 CET
Join us for an engaging and educational webinar on the topic of “Exploring Oncology Clinical Design”. This webinar will provide you with valuable insights and the latest information on oncology clinical design.
You’ll have the opportunity to hear from expert speakers who will share their experience and knowledge on the subject. Whether you’re a healthcare professional, researcher, or simply interested in the field of oncology, this webinar is a must-attend event. Register now to secure your spot!
The webinar will lead by our field experts, who share their experiences and best practices. So let’s dive in and explore the complexities and opportunities of Oncology Clinical Trial Design.
During the webinar we’ll discuss:
- Dose escalation designs
- Early phase study – endpoints
- Protocol – schedule of assessment considerations
Register here!
Regina Auskalnienė - MD
Chief Global Clinical Research Officer
Regina Auskalniene is a Medical Doctor, cardiologist. She has over 13 years of experience in Clinical Research and has been leading our Clinical Operations department since April 2018, overseeing Clinical Monitoring, Project Management and Start-up activities in the region.
Read more.
Vladimir Mukovozchik, MD
Head of Project Management
Vladimir has over 16 years of experience in clinical research. He has been working in global CROs on managerial roles for many years and has been leading our project management department since 2022. He has extensive experience in different therapeutic areas with the main expertise lying in the oncology field.
Planning Your Next Oncology Trial?
Let’s talk how we can help you design oncology trials that get you the results you need to improve patient lives.
Other content that might interest you:
Clinical Safety Outsourcing: When It Makes Sense for Biotech Companies
Learn when clinical safety outsourcing becomes the right choice for biotechs and how clinical safety management supports growing clinical trials.
When Do Biotech Companies and Startups Need Pharmacovigilance
Many biotech startups assume pharmacovigilance begins after approval, but regulatory expectations and clinical trial complexity often require safety oversight much earlier. Learn when pharmacovigilance becomes essential and how to stay compliant as you scale.
How to Build Clinical Safety for Biotechs Without a Full Department
Discover how biotech companies can build scalable clinical safety management early, ensuring compliance, oversight, and efficient operations across development phases.
